Survival and Prognostic Factors of Patients Operated for Bronchopulmonary Cancer Invading the Chest Wall at Ibn Sina Hospital in Rabat (Morocco)

Author:

DAMESSANE LAMBONI,Fenane Hicham,Taoufiq Rachid,Sabur Safa,Caidi Mohamed,Achir Abdellah,Bouchikh Mohamed

Abstract

Introduction: Non-small cell bronchopulmonary cancer (NSCLC) invading the chest wall is operable cancer at the cost of a parietal sacrifice. Their survival is estimated at 15% at 5 years in the literature. The factors of poor prognosis, particularly recurrence, have been studied in the literature in various ways.Objective of this study is to describe the overall survival and the recurrence-free survival of patients operated on in our department for NSCLC invading the chest wall (parietal pleura and bone wall) and to assess prognostic factors.Material and methods: We carried out a retrospective study on a series of cases of bronchopulmonary cancer invading the chest wall operated on in our department between 2010 and 2014. We analyzed overall and recurrence-free survival according to the Kaplan-Meier method depending of several parameters.Results: Twenty-nine patients were operated on, all of them male, with an average age of 57 years. The main clinical sign was chest pain. Bone involvement was found in 7 patients, 22 patients presented with an invasion of the parietal pleura alone. The resection was in one piece, removing the pulmonary parenchyma and the wall in 23 patients. Parenchymal resections were dominated by lobectomy performed in 23 patients (79.31%). Seven patients were lost to follow-up. The overall survival of the patients is on average 34 +/- 4.9 months and the survival without recurrence is 24 months +/- 5.53 months. We analyzed overall survival as a function of bone involvement, monobloc resection and association with perioperative treatment. The chi-square test was respectively p = 0.659; p = 0.194; p = 402. Survival without recurrence was analyzed according to the same parameters with p = 0.197; p = 0.050; p = 0.036.Conclusion: NSCLCs invading the chest wall are not limits to surgical resection. The association with perioperative adjuvant treatment seems to have an impact on the improvement of survival and on the occurrence of recurrence.

Publisher

Mediterranean BioMedical Journals

Reference22 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

2. Recommandations professionnelles Cancer du poumonnon à petites cellules.Collection Recommandations & référentiels, INCa, Boulogne-Billancourt, septembre 2010

3. National Cancer Institute . SEER [Cited 25 feb 2019.] Available from URLExplorer 2019 https://seer.cancer.gov/explorer/application.php?site=47&data_type=1&graph_type=4&compareBy=sex&chk_sex_3=3&chk_sex_2=2&chk_race_1=1&chk_age_range_1=1&advopt_precision=1&showDataFor=race_1_and_age_range_1

4. Lung cancer with chest wall invasion: retrospective analysis comparing en-bloc resection and ‘resection in bird cage’

5. Chest wall involvement by lung cancer: Computed tomographic detection and results of operation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3